The COVID-19 Testing Environment & the Role Testing will Play in “Return to Normalcy”

Insight by

Doug Schenkel, Cowen’s Life Science & Diagnostic Tools analyst speaks with Nathan Ledeboer, Ph.D.Professor, Pathology and Medical Director of Microbiology and Molecular Diagnostics Laboratories, Froedtert & the Medical College of Wisconsin. They discuss how COVID-19 testing has evolved over the past several weeks and some current bottlenecks contributing to the inability to test on a wide scale basis.  They also speak about the broader use of molecular diagnostics and how diagnostic tests such as serologic tests can be used to reopen the economy.

Press play below to listen to their conversation.

Cowen Host:

Doug Schenkel, Managing Director, Health Care – Life Science & Diagnostic Tools

Guest:

Nathan Ledeboer, Ph.D.

Nathan Ledeboer, Ph.D. is Professor of Pathology and Medical Director of Microbiology and Molecular Diagnostics Laboratories at Froedtert & the Medical College of Wisconsin. Dr. Ledeboer’s primary responsibility is for the medical and technical oversight of the Clinical Microbiology and Molecular Diagnostics Laboratories. In this role he oversees development and implementation of new assays, oversees and sign out all testing performed in these laboratories, and consults with physician colleagues regarding test results and selection. His research interests include the development of rapid molecular techniques for detection of infectious diseases and molecular detection and epidemiology of respiratory viruses.

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Podcast

Street Cred Ep 9 | Ad Com for COVID-19: Vaccines Likely to Underwhelm

Read More
Ahead of the Curve®

Updated Survey: Impact of COVID-19 on Medical Technology Spending

Read More
Ahead of the Curve®

Liquid Biopsy: Early Detection of a Huge Investment Opportunity

Read More